SCHEMBL3430971

SCHEMBL3430971

O=C(O)Oc1cc(-c2cccc(OCc3ccccc3)c2)n(-c2cccc(Cl)c2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC16A3 O15427 3/20 0.50
SLC16A1 P53985 3/20 0.50
MCTS1 Q9ULC4 1/20 0.50
MDM2 Q00987 2/20 0.49
SLC5A1 P13866 4/20 0.46
FABP3 P05413 3/20 0.46
FABP4 P15090 3/20 0.46
RXRA P19793 1/20 0.46
RXRB P28702 1/20 0.46
RXRG P48443 1/20 0.46
JAK2 O60674 1/20 0.45
JAK1 P23458 1/20 0.45
NR4A2 P43354 1/20 0.45
PTGER1 P34995 1/20 0.44
BCL2 P10415 1/20 0.43
MCL1 Q07820 1/20 0.43
PPP1CA P62136 1/20 0.43
BCHE P06276 1/20 0.43
LIPC P11150 1/20 0.43
ACHE P22303 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3429446 0.89 SLC16A3 (0.48) SLC16A3SLC16A1MCTS1MDM2SLC5A1
SCHEMBL3431206 0.88 SLC16A3 (0.49) SLC16A3SLC16A1MCTS1SLC5A1FABP3
SCHEMBL3431275 0.86 SLC16A3 (0.48) SLC16A3SLC16A1MCTS1SLC5A1FABP3
SCHEMBL1765293 0.86 MDM2 (0.68) SLC16A3SLC16A1MCTS1MDM2RXRA
SCHEMBL3428415 0.85 SLC16A3 (0.52) SLC16A3SLC16A1MCTS1SLC5A1FABP3
SCHEMBL1110857 0.85 PPP1CA (0.57) SLC16A3SLC16A1MCTS1FABP3FABP4
SCHEMBL3430532 0.84 SLC16A3 (0.62) SLC16A3SLC16A1MCTS1PPP1CA
SCHEMBL1110690 0.82 SLC5A1 (0.55) SLC16A3SLC16A1MCTS1SLC5A1PPP1CA
SCHEMBL3429113 0.81 HRH3 (0.54)
SCHEMBL1764908 0.81 FAAH (0.59) SLC16A3SLC16A1MCTS1MDM2BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2254885-A1 (PYRAZOLYL CARBONYL)IMIDAZOLIDINONE DERIVATIVES FOR THE TREATMENT OF RETROVIRAL DISEASES AiCuris GmbH & Co. KG (DE) 2010-12-01 EP disclosed
WO-2009115213-A1 (PYRAZOLYL CARBONYL)IMIDAZOLIDINONE DERIVATIVES FOR THE TREATMENT OF RETROVIRAL DISEASES AICURIS GMBH & CO. KG (DE) 2009-09-24 WO disclosed